Abstract:Full-length p53 (p53α) plays a pivotal role in maintaining genomic integrity and preventing tumor development. Over the years, p53 was found to exist in various isoforms, which are generated through alternative splicing, alternative initiation of translation, and internal ribosome entry site. p53 isoforms, either C-terminally altered or N-terminally truncated, exhibit distinct biological roles compared to p53α, and have significant implications for tumor development and therapy resistance. Due to a lack of part and/or complete C- or N-terminal domains, ectopic expression of some p53 isoforms failed to induce expression of canonical transcriptional targets of p53α like CDKN1A or MDM2 , even though they may bind their promoters. Yet, p53 isoforms like Δ40p53α still activate subsets of targets including MDM2 and BAX . Furthermore, certain p53 isoforms transactivate even novel targets compared to p53α. More recently, non-canonical functions of p53α in DNA repair and of different isoforms in DNA replication unrelated to transcriptional activities were discovered, amplifying the potential of p53 as a master regulator of physiological and tumor suppressor functions in human cells. Both regarding canonical and non-canonical functions, alternative p53 isoforms frequently exert dominant negative effects on p53α and its partners, which is modified by the relative isoform levels. Underlying mechanisms include hetero-oligomerization, changes in subcellular localization, and aggregation. These processes ultimately influence the net activities of p53α and give rise to diverse cellular outcomes. Biological roles of p53 isoforms have implications for tumor development and cancer therapy resistance. Dysregulated expression of isoforms has been observed in various cancer types and is associated with different clinical outcomes. In conclusion, p53 isoforms have expanded our understanding of the complex regulatory network involving p53 in tumors. Unraveling the mechanisms underlying the biological roles of p53 isoforms provides new avenues for studies aiming at a better understanding of tumor development and developing therapeutic interventions to overcome resistance.

Transcription Dependent and Independent Roles of p53 in Apoptosis Regulation

Coordination of the Nuclear and Cytoplasmic Activities of P53 in Response to DNA Damage

Coordination of miR-192 and miR-22 in p53-Mediated Cell Fate Decision.

A Two-Step Mechanism For Cell Fate Decision By Coordination Of Nuclear And Mitochondrial P53 Activities

The multiple mechanisms that regulate p53 activity and cell fate

Essential Role for Caspase-8 in Transcription-independent Apoptosis Triggered by P53

Involvement of miR-605 and miR-34a in the DNA damage response promotes apoptosis induction.

Regulation of the DNA damage response by p53 cofactors.

Role of p53 in the Regulation of Cellular Senescence

Coordination Between P21 and DDB2 in the Cellular Response to UV Radiation.

Modeling the Role of P53 Pulses in DNA Damage- Induced Cell Death Decision

Decision Making of the P53 Network: Death by Integration

Cell Fate Decision Mediated by P53 Pulses

Mitogen-Activated Protein Kinase Phosphatase 2 : A Novel Transcription Target of P 53 in Apoptosis

TFIIS.h, a New Target of P53, Regulates Transcription Efficiency of Pro-Apoptotic Bax Gene

Canonical and non-canonical functions of p53 isoforms: potentiating the complexity of tumor development and therapy resistance

Multiple roles of p53 in cancer development: Regulation of tumor microenvironment, m6A modification and diverse cell death mechanisms

p53 family in development.

Cellular adaptation to hypoxia and p53 transcription regulation

A Conserved Mechanism for Binding of p53 DNA-Binding Domain and Anti-Apoptotic Bcl-2 Family Proteins

P53 Transcriptional Activity is Essential for P53-Dependent Apoptosis Following DNA Damage